UBS Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66M Buy
559,415
+369,748
+195% +$3.78M ﹤0.01% 3769
2025
Q4
$1.89M Buy
189,667
+14,182
+8% +$135K ﹤0.01% 5034
2025
Q3
$1.57M Sell
175,485
-162,047
-48% -$1.5M ﹤0.01% 5190
2025
Q2
$3.18M Buy
337,532
+26,635
+9% +$235K ﹤0.01% 4337
2025
Q1
$3.37M Buy
310,897
+22,468
+8% +$226K ﹤0.01% 4204
2024
Q4
$2.75M Buy
288,429
+248,886
+629% +$2.52M ﹤0.01% 4416
2024
Q3
$444K Sell
39,543
-1,297
-3% -$13.8K ﹤0.01% 5315
2024
Q2
$408K Sell
40,840
-63,790
-61% -$648K ﹤0.01% 5164
2024
Q1
$1.2M Sell
104,630
-55,429
-35% -$471K ﹤0.01% 4456
2023
Q4
$1.17M Buy
160,059
+66,018
+70% +$520K ﹤0.01% 4357
2023
Q3
$856K Sell
94,041
-49,206
-34% -$590K ﹤0.01% 4215
2023
Q2
$1.74M Buy
143,247
+95,676
+201% +$1.07M ﹤0.01% 3671
2023
Q1
$591K Sell
47,571
-13,903
-23% -$256K ﹤0.01% 4563
2022
Q4
$1.18M Buy
61,474
+23,849
+63% +$504K ﹤0.01% 3912
2022
Q3
$707K Sell
37,625
-56,403
-60% -$1.16M ﹤0.01% 4040
2022
Q2
$1.7M Sell
94,028
-90,950
-49% -$1.48M ﹤0.01% 3287
2022
Q1
$2.96M Sell
184,978
-17,806
-9% -$320K ﹤0.01% 3064
2021
Q4
$4.96M Sell
202,784
-414,985
-67% -$9.74M ﹤0.01% 2827
2021
Q3
$14.4M Sell
617,769
-213,275
-26% -$5.16M ﹤0.01% 1756
2021
Q2
$22.8M Buy
831,044
+711,589
+596% +$20.3M 0.01% 1398
2021
Q1
$4.39M Sell
119,455
-4,126
-3% -$146K ﹤0.01% 2756
2020
Q4
$4.64M Buy
123,581
+114,952
+1,332% +$3.56M ﹤0.01% 2523
2020
Q3
$188K Buy
8,629
+7,974
+1,217% +$167K ﹤0.01% 4829
2020
Q2
$11K Buy
+655
New +$10.9K ﹤0.01% 6933
2020
Q1
Sell
-198
Closed -$2K 7918
2019
Q4
$2K Sell
198
-352
-64% -$3.5K ﹤0.01% 7813
2019
Q3
$6K Buy
550
+50
+10% +$510 ﹤0.01% 7389
2019
Q2
$5K Hold
500
﹤0.01% 7361
2019
Q1
$5K Hold
500
﹤0.01% 7143
2018
Q4
$5K Buy
+500
New +$4.9K ﹤0.01% 7534

Other funds holding AHCO